Enabling oral novel Taxanes-based Chemotherapy with Lipophilic prodrug Self-nanoemulsifying drug delivery system
Bioorganic Chemistry · 2024-12 · 153 · 107902
DOI: 10.1016/j.bioorg.2024.107902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024-12. Verfasst von Yifan Miao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Drug Delivery Systems, Emulsions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Liaoning Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Larotaxel (LTX) and SB-T-1214 (SBT), two new synthetic experimental toxoids, have shown broad-spectrum antitumor activity, especially against tumors that are resistant to other drugs. However, their poor solubility, membrane permeability, and first-pass effect limits their use in oral administration. We designed and synthesized two long-chain triglyceride-mimic prodrugs of LTX (LTXSSTG) and SBT (SBTSSTG), which are bridged by disulfide bonds and efficiently incorporated them into Self-nanoemulsifying drug delivery system (SNEDDS). These prodrugs can bypass hepatic metabolism by entering the blood through intestinal lymphatic transport, following a similar oral absorption pathway to dietary lipids. It was found that LTXSSTG and SBTSSTG significantly improved oral bioavailability (about 4.5-fold for LTX and 3.4-fold for SBT) compared to their solution forms. Moreover, with LTXSSTG and SBTSSTG incorporating reduction stimulus-responsive spacer were much more effective in suppressing tumor growth in vivo with eliminated adverse effects than solution form. To sum up, this strategy provides a new avenue to enhance oral delivery of new toxoids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang 110016, China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang 110016, China. Electr…
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Liaoning Province
- Scientific Research Fund of Liaoning Provincial Education Department
Zitieren
APA
Miao, Y., Liu, J., Xiao, H., Deng, J., Xu, W., Zhao, C., Lu, Q., He, Z., Sun, B., Tian, C., & Sun, J. (2024). Enabling oral novel Taxanes-based Chemotherapy with Lipophilic prodrug Self-nanoemulsifying drug delivery system. Bioorganic Chemistry, 153, 107902. https://doi.org/10.1016/j.bioorg.2024.107902
Vancouver
Miao Y, Liu J, Xiao H, Deng J, Xu W, Zhao C, et al. Enabling oral novel Taxanes-based Chemotherapy with Lipophilic prodrug Self-nanoemulsifying drug delivery system. Bioorganic Chemistry. 2024;153:107902. doi:10.1016/j.bioorg.2024.107902
BibTeX
@article{Miao2024,
author = {Miao, Yifan and Liu, Jinrui and Xiao, Hongying and Deng, Jia and Xu, Wenqian and Zhao, Can and Lu, Qian and He, Zhonggui and Sun, Bingjun and Tian, Chutong and Sun, Jin},
title = {Enabling oral novel Taxanes-based Chemotherapy with Lipophilic prodrug Self-nanoemulsifying drug delivery system},
journal = {Bioorganic Chemistry},
year = {2024},
volume = {153},
pages = {107902},
doi = {10.1016/j.bioorg.2024.107902}
}
EUVIMED